Identification
Personal identification
- Full name
- Margarida Saraiva
Citation names
- Saraiva, Margarida
Author identifiers
- Ciência ID
- E913-D1B0-CEB1
- ORCID iD
- 0000-0002-8180-1293
- Scopus Author Id
- 35079223500
Email addresses
- margarida.saraiva@ibmc.up.pt (Professional)
Addresses
- Rua Alfredo Allen, 208, 4200-135, Porto, Porto, Portugal (Professional)
Websites
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Immunology
Languages
| Language | Speaking | Reading | Writing | Listening | Peer-review |
|---|---|---|---|---|---|
| Portuguese (Mother tongue) | |||||
| English (Mother tongue) |
Education
| Degree | Classification | |
|---|---|---|
|
2003
Concluded
|
Doutoramento em Patologia (Doutoramento)
University of Cambridge Murray Edwards College, United Kingdom
"Immunomodulatory molecules encoded by poxviruses- TNF receptor homologues." (THESIS/DISSERTATION)
|
aprovado por unanimidade |
|
1997
Concluded
|
Bioquímica (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"n/a" (THESIS/DISSERTATION)
|
17 |
Affiliation
Science
| Category Host institution |
Employer | |
|---|---|---|
| 2015/06/01 - Current | Principal Investigator (Research) | Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal |
| Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal | ||
| 2013/05/01 - 2015/05/30 | Principal Investigator (Research) | Universidade do Minho, Portugal |
| Laboratório Associado ICVS 3B's, Portugal | ||
| 2007/04/01 - 2013/04/30 | Auxiliary Researcher (Research) | Universidade do Minho, Portugal |
| Laboratório Associado ICVS 3B's, Portugal | ||
| 2006/01/03 - 2007/03/31 | Invited Auxiliary Researcher (Research) | National Institute for Medical Research, United Kingdom |
| 2003/01/03 - 2005/12/31 | Postdoc (Research) | National Institute for Medical Research, United Kingdom |
| 1997/09/01 - 1998/12/31 | Research Trainee (Research) | Universidade do Porto, Portugal |
| Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal |
Projects
Grant
| Designation | Funders | |
|---|---|---|
| 2021/03/01 - Current | Host-microbiome interactions in the quest for Fibrosing ILD Biomarkers that Rule Acceleration (FIBRA-Lung)
PTDC/MEC-RES/0158/2020
Researcher
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2021/09/15 - 2025/09/15 | A multidisciplinary approach to understand host and pathogen interactions to develop new strategies to target TB
HR21-00415
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
La Caixa Research Foundation
Ongoing
|
| 2022/01/01 - 2025/05/30 | Deciphering the immune mechanisms of tuberculosis disease severity through host-pathogen interactions
PTDC/SAU-INF/1172/2021
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2018/08/27 - 2021/08/26 | Understanding host-pathogen interactions in tuberculosis: lessons from Mycobacterium africanum.
Maf_TB
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Fundação para a Ciência e a Tecnologia Aga Khan Foundation Ongoing
|
| 2018/06/01 - 2021/05/31 | Molecular stratification of latent tuberculosis: a persisting memory?
POCI-01-0145-FEDER-028955
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
| 2014/09/01 - 2017/04/01 | Deregulation of hematopoiesis by IL-10: implications for the development of hematologic diseases
FCT-ANR/BIM-MEC/0007/2013
Principal investigator
Laboratório Associado ICVS 3B's, Portugal
Institut Pasteur, France |
Concluded
|
| 2010/03/01 - 2013/02/28 | Molecular mechanisms underlying regulation of IL-12 family of cytokines expression on macrophages and dendritic cells infected
by Mycobacterium tuberculosis
PTDC- BIA-BCM/102776/2008
Principal investigator
Laboratório Associado ICVS 3B's, Portugal
|
Concluded
|
Contract
| Designation | Funders | |
|---|---|---|
| 2019/03/01 - 2025/02/28 | Deciphering host-pathogen interactions to understand tuberculosis
CEECIND/00241/2017
Principal investigator
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Ongoing
|
| 2021/03/01 - 2024/02/29 | Interações hospedeiro-microbioma na busca por biomarcadores de doenças pulmonares intersticiais fibrosantes que regem a aceleração
FIBRA-Lung<br>
PTDC/MEC-RES/0158/2020
Centro Hospitalar Universitário de São João, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal Universidade do Porto Faculdade de Medicina, Portugal |
Fundação para a Ciência e a Tecnologia
Ongoing
|
Outputs
Publications
| Book |
|
| Journal article |
|
Activities
Oral presentation
| Presentation title | Event name Host (Event location) |
|
|---|---|---|
| 2025/02/18 | Genetically diverse M. tuberculosis clinical isolates modulate IL-1ß responses with an impact on the outcome of infection | Tuberculosis: Heterogeneity from Experimental Models to Human Disease
Keystone symposium (Boston, United States)
|
| 2024/03/05 | Mycobacterium tuberculosis diversity: what is it teaching us | 27. Symposium: “Infection and Immune Defense“ - German Society for Immunology
German Society for Immunology - Study Group Infection Immunology (Germany)
|
| 2023/12 | TB-spectrum: laboratory markers in connection with clinical significance | Training school of the Advance-TB COST Action |
| 2023/06 | Study of host pathogen interactions in TB using in clinico to in vitro to in vivo approaches- What can we learn? | European Society of Mycobacteriology
(Albania)
|
| 2023/03/19 | Tuberculosis basic Biology- using Mycobacterium tuberculosis diversity to understand tuberculosis | Tuberculosis symposium
Basel TPH (Basel, Switzerland)
|
Supervision
| Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
|---|---|---|
| 2024/09/01 - Current | Redefining IL-10-based therapies
Supervisor
|
|
| 2021/01/01 - Current | Understanding tuberculosis infection and disease progression using Mycobacterium africanum as a model
Supervisor
|
PhD (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2020/09/01 - Current | Understanding the molecular bases dictating TB severity
Supervisor
|
PhD in Molecular and Cell Biology (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2023/01/01 - 2026/12/31 | Deciphering the contribution of the epithelium to tuberculosis severity: from alveolar epithelial cells to epithelioid
macrophages
Supervisor
|
PhD in Molecular and Cell Biology (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
| 2023/01/01 - 2026/12/31 | Improved predictive models for SARS-CoV-2 infection
Co-supervisor
|
PhD in Molecular and Cell Biology (PhD)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
| 2019/09/01 - 2024/01 | Exploring Mycobacterium tuberculosis immune evasion strategies to improve host immunity and tuberculosis outcome: the IL-1
axis
Supervisor
|
Doutoramento em Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2017/09/01 - 2023/09/25 | Decoding the mechanisms linking IL-10-driven to cellular senescence and aging
Supervisor
|
Doutoramento em Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2021/09/01 - 2022/12/03 | Deciphering the in vivo mechanisms underlying the IL-10-mediated differentiation of IFNg-producing T cells
Supervisor
|
Universidade do Porto Faculdade de Ciências, Portugal
|
| 2021/09/01 - 2022/12/03 | Understanding the impact of the Mycobacterium tuberculosis complex diversity in tuberculosis
Supervisor
|
Universidade do Porto Faculdade de Ciências, Portugal
|
| 2021/09/01 - 2022/09/01 | Understanding the modulation of myeloid cell responses by clinical isolates of Mycobacterium tuberculosis associated with
mild or severe tuberculosis
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2020/09/01 - 2021/12/03 | Interleukin
1
manipulation by
Mycobacterium
tuberculosis :
impact to the
infection
establishment and
progression
Supervisor
|
Universidade do Porto Faculdade de Ciências, Portugal
|
| 2016/01/01 - 2020/03/04 | Impact of Host Glycosylation in Tuberculosis
Supervisor
|
Doutoramento em Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2015/10/01 - 2020/01/28 | UNDERSTANDING HOST-PATHOGEN INTERACTIONS IN TUBERCULOSIS: LESSONS FROM MYCOBACTERIUM AFRICANUM
Supervisor
|
Doutoramento em Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2015/11/01 - 2020/01/14 | THE YIN AND YAN OF HOST-PATHOGEN INTERACTIONS IN TUBERCULOSIS
Supervisor
|
Doutoramento em Biologia Molecular e Celular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2018 - 2019 | The impact of Mycobacterium tuberculosis diversity to the course of infection
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2013/01/01 - 2018/07/19 | Impact of regulatory cytokines in hematopoiesis
Supervisor
|
Doutoramento em Ciências da Saúde (PhD)
Universidade do Minho Escola de Medicina, Portugal
|
| 2013/01/01 - 2017/04/17 | IDENTIFICATION OF HUMAN AND PATHOGEN MOLECULAR VARIANTS ASSOCIATED TO TUBERCULOSIS HETEROGENEITY
Supervisor
|
Doutoramento em Medicina (PhD)
Universidade do Minho Escola de Medicina, Portugal
|
| 2016 - 2017 | Decoding the role of IL-10 in aging
Supervisor
|
Universidade do Minho Escola de Ciências, Portugal
|
| 2016 - 2017 | Funtional impact of differential IL-1 signaling in tuberculosis
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
| 2015 - 2016 | IL-10 overexpression drives myelopoiesis and premature aging
Supervisor
|
Universidade do Porto Faculdade de Ciências, Portugal
|
| 2014 - 2015 | The mechanisms underlying Mycobacterium tuberculosis virulence granted by the nrp gene
Supervisor
|
Universidade do Minho Escola de Medicina, Portugal
|
| 2014 - 2015 | Impact of IL-10 over-expression in dextran sodium sulfate induced acute and chronic colitis
Supervisor
|
Universidade do Minho Escola de Medicina, Portugal
|
Event participation
| Activity description Type of event |
Event name Institution / Organization |
|
|---|---|---|
| 2018/07/01 - Current | Invited speaker @ the 2018 Annual Meeting of the European Society for Mycobacteriology
Congress
|
Annual Meeting of the European Society for Mycobacteriology |
| 2018 - Current | Invited speaker @ The Francis Crick Institute, London
Seminar
|
|
| 2017/03/04 - Current | Invited speaker @ the 2017 EFIS on the road symposium
Symposium
|
Meeting of the European Federation of Immunological Societies |
| 2017 - Current | Invited speaker @ Max Plank Institute for Infection, Berlin
Seminar
|
Invited seminar - Max Plank Institute for Infection |
| 2022/10/22 - 2022/10/22 | Invited speaker at the Innovate4TB annual meeting
Congress
|
|
| 2022/06/22 - 2022/06/22 | Invited speaker at the Inflammazoom seminar series
Conference
|
|
| 2022/04/20 - 2022/04/20 | Invited speaker at the Annual Meeting of the Portuguese Society for Immunology 2022
Congress
|
|
| 2021/06/07 - 2021/06/07 | Invited speaker at IMM seminar series
Conference
|
|
| 2020/10/03 - 2020/10/03 | Invited speaker at TB-Science 2020
Conference
|
|
| 2020/06/04 - 2020/06/04 | Invited speaker at the IGC seminar series
Conference
|
Committee member
| Activity description Role |
Institution / Organization | |
|---|---|---|
| 2020/02/01 - Current | Member of the Scientific Advisory Board for a H2020 project
Member
|
|
| 2020 - Current | Member of the Scientific Advisory Board of the PhD program Molecular and Cellular Biology
Member
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
| 2018/06/05 - Current | President of the Portuguese Society for Immunology
President / Vice-president
|
Sociedade Portuguesa de Imunologia, Portugal |
| 2024/01 - 2026/12 | Member of the Scientific Council of the Jerome Lejeune foundation
Advisor / Consultant
|
Fondation Jérôme Lejeune, France |
| 2022/10/01 - 2025/09/30 | Management Committee and Work Group Leader - COST Action TB Advance
Member
|
Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Spain |
| 2020/01/01 - 2024/01/01 | Scientific Advisory Board Member- EU project SMA-TB
Advisor / Consultant
|
Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Spain |
| 2015/06/01 - 2018/12/30 | Member of the management committee of the COST Action MyeEUNITER
Member
|
Evaluation committee
| Activity description Role |
Institution / Organization | Funding entity | |
|---|---|---|---|
| 2023/06/14 - 2033/06/15 | Member of the Life Sciences panel for the La Caixa PhD fellowships.
Evaluator
|
La Caixa Research Foundation, Spain | |
| 2024/06/01 - 2024/10 | Co-coordinator of the Experimental Biology panel of the FCT PhD fellowships call
Coordinator
|
Journal scientific committee
| Journal title (ISSN) | Publisher | |
|---|---|---|
| 2015/04/01 - Current | Immunity Inflammation and Disease (2050-4527) | Wiley (John Wiley & Sons) |
Other jury / evaluation
| Activity description | Institution / Organization | |
|---|---|---|
| 2014 - 2015 | Member of the Evaluation panel for PhD and Post-doctoral fellowships - FCT | Fundação para a Ciência e a Tecnologia, Portugal |
Distinctions
Other distinction
| 2021 | Testing and defining the correlates of protection to a new inhaled COVID-19 vaccine.
British Society for Antimicrobial Chemotherapy, United Kingdom
|
| 2018 | Host prognostic markers of effective Mycobacterium tuberculosis infection in latency.
British Society for Antimicrobial Research , United Kingdom
|
| 2018 | Janssen Award for Innovation – Honorable distinction: The anti-inflammatory cytokine IL-10 is a new determinant of hematopoietic lineage commitment. 2018. |
| 2015 | 2015 Research Grant from the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)- Deciphering the candidate Mycobacterium tuberculosis molecular signatures of TLR2 vs TLR4 activation. |
| 2013 | Fundação Amélia de Mello/José de Mello Saúde Prize for clinical research |
| 2013 | Royal Academy of Sciences Exchange Research Prize |
| 2011 | ICVS-Incentive to Reseach |
